Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer
about
L-929 cells harboring ectopically expressed RelA resist curcumin-induced apoptosisProtein phosphatase 2A interacts with and directly dephosphorylates RelABreast cancer metastasis suppressor 1 functions as a corepressor by enhancing histone deacetylase 1-mediated deacetylation of RelA/p65 and promoting apoptosis.Expression of SCC-S2, an antiapoptotic molecule, correlates with enhanced proliferation and tumorigenicity of MDA-MB 435 cellsDJ-1 enhances cell survival through the binding of Cezanne, a negative regulator of NF-kappaBUnraveling insulin-like growth factor binding protein-3 actions in human diseaseThe putative oncoprotein Bcl-3 induces cyclin D1 to stimulate G(1) transitionIkB kinase alpha: a link in the chain of the mammary cycle.New insights into the role of nuclear factor-kB in cell growth regulationThe role of galectin-4 in physiology and diseases.Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic ApproachesMinireview: Inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancersThe RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cellsDisruption of hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-kappaB activationTo be, or not to be: NF-kappaB is the answer--role of Rel/NF-kappaB in the regulation of apoptosisTyrosine phosphorylation-dependent activation of NF-kappa B. Requirement for p56 LCK and ZAP-70 protein tyrosine kinasesVCP (p97) regulates NFkappaB signaling pathway, which is important for metastasis of osteosarcoma cell lineThe non-genomic crosstalk between PPAR-gamma ligands and ERK1/2 in cancer cell linesInterleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKsBrucea javanica oil induces apoptosis in T24 bladder cancer cells via upregulation of caspase-3, caspase-9, and inhibition of NF-kappaB and COX-2 expressionsTo NFκB or not to NFκB: The Dilemma on How to Inhibit a Cancer Cell Fate RegulatorHydrogen sulfide-releasing naproxen suppresses colon cancer cell growth and inhibits NF-κB signalingNuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progressionEstrogen withdrawal-induced NF-kappaB activity and bcl-3 expression in breast cancer cells: roles in growth and hormone independenceNitrosylcobalamin potentiates the anti-neoplastic effects of chemotherapeutic agents via suppression of survival signalingTranscriptional activation of TINF2, a gene encoding the telomere-associated protein TIN2, by Sp1 and NF-κB factorsRole of F-box protein betaTrcp1 in mammary gland development and tumorigenesisActivating transcription factor 3 is integral to the eukaryotic initiation factor 2 kinase stress responseAnticancer compound plumbagin and its molecular targets: a structural insight into the inhibitory mechanisms using computational approachesTwo carboxyl-terminal activation regions of Epstein-Barr virus latent membrane protein 1 activate NF-kappaB through distinct signaling pathways in fibroblast cell linesMullerian inhibiting substance regulates NFkappaB signaling and growth of mammary epithelial cells in vivoTelomere-independent Rap1 is an IKK adaptor and regulates NF-kappaB-dependent gene expressionExpression of the aryl hydrocarbon receptor/transcription factor (AhR) and AhR-regulated CYP1 gene transcripts in a rat model of mammary tumorigenesisBCL2 and CASP8 regulation by NF-kappaB differentially affect mitochondrial function and cell fate in antiestrogen-sensitive and -resistant breast cancer cells.K-Ras promotes angiogenesis mediated by immortalized human pancreatic epithelial cells through mitogen-activated protein kinase signaling pathways.Investigation into the controversial association of Streptococcus gallolyticus with colorectal cancer and adenoma.Similar NF-κB gene signatures in TNF-α treated human endothelial cells and breast tumor biopsies.Reactive oxygen species from NAD(P)H:quinone oxidoreductase constitutively activate NF-kappaB in malignant melanoma cells.Characterization of anti-NF-kappaB RNA aptamer-binding specificity in vitro and in the yeast three-hybrid system.Growth suppression of mouse pituitary corticotroph tumor AtT20 cells by curcumin: a model for treating Cushing's disease.
P2860
Q22253415-E52CBE94-27F1-49ED-857A-CBF51E8B449AQ24291769-47462200-E162-473A-AAA1-F0766755ED6CQ24304385-2CB5A52D-2CCA-4430-B51B-9C50DBC719F6Q24304993-4216114B-8DF8-405A-A065-8DF22C0A4B25Q24307823-CC854C7C-05CB-4874-9BD5-C19A0E3B7910Q24650060-473790ED-FFD9-4811-B071-79990B00B9A0Q24746253-271E4D59-256B-4733-91E0-A7F4D5257825Q24802711-96931B70-3FFB-4ED9-9D39-F3DBBF6277D8Q26058119-81443196-5EA6-40D6-B96F-9427EBB639D8Q26750700-E8183984-FEF9-4255-B2BD-6D0E3FBEB0DAQ26752576-726E0C69-B0C2-4EE6-AADE-6973AC43E3E7Q27016106-CC5441C1-8F6E-4A75-8EFB-AF4786794951Q28140206-94915D2C-E483-4301-8F69-34F820F6F124Q28140363-CB71914E-ADC2-48F1-ACC7-836E2F6AD143Q28190313-CA72A410-B6F4-49C4-AEDF-2158D2153876Q28202880-FC995179-63E4-4A1E-AA39-CB3327425A31Q28211966-4AC072D8-FCB1-4606-A2DD-EDABB6D4E686Q28238709-52C07319-671A-4498-90FE-8695692C181CQ28239808-FF0C40D6-EA22-47FE-A340-417AD5EE7077Q28283477-DD74D5D0-E4AE-4A21-AF38-1D2E85777CDDQ28386593-69CC450F-DE6A-4F81-A7C6-70B40F39CFE3Q28387183-DED18493-226F-4B67-9F53-69032D4D908AQ28389404-6DD9A83C-66D0-4AE9-BE9F-1866185CAA67Q28396413-20B1AACE-F6CA-4514-B849-B081039F0CA2Q28471740-3AA4A14D-BDC2-4F14-8527-CB35B02A191DQ28478698-CCD9F684-B2A7-4CCD-BD1F-5B70D84D7D1EQ28508088-55932E46-FB03-4497-A967-C33F2CA79F78Q28508156-CFD112CE-4DAD-46F8-9370-6C79C146301CQ28540187-0A6C94AD-F6E0-407D-9E2B-2B1F826BB811Q28565703-9210A532-3A91-4A70-95D9-205A0925637AQ28577022-32B7DD54-ADD0-4B25-BBDE-4A7D87E507CAQ28587192-9160F60D-D045-4C29-801C-248497961EBAQ28645937-BF22F947-A617-47DD-9826-0136278363C8Q30432099-F6D16C76-1FEE-4834-99BE-8FB8AF251C4CQ30608512-C5643482-78E1-49A1-A243-2ED724F1E57DQ30899032-853316E3-9FA5-4372-8391-A7AEB943FE79Q31022986-F5B306B4-7A47-44FE-9428-39C56D406422Q31919510-7AD3616E-43FD-483F-BCBD-C2091E7CD456Q33495466-A0A193ED-EB62-4DD1-8EAE-65E47060D084Q33559806-A9B7B7FD-C902-4CF8-9FD6-80620276A716
P2860
Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 1997
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer
@en
Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.
@nl
type
label
Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer
@en
Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.
@nl
prefLabel
Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer
@en
Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.
@nl
P2093
P2860
P356
P1476
Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer
@en
P2093
Sonenshein GE
Zanieski GJ
P2860
P304
P356
10.1172/JCI119848
P407
P577
1997-12-01T00:00:00Z